Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Matthew Pianko MD

Matthew Pianko MD

Clinical Assistant Professor, University of Michigan, Ann Arbor, MI

Matthew Pianko, MD, is a clinical assistant professor at the University of Michigan and associate member of the Rogel Cancer Center. He is a clinical investigator focused on the care of patients with plasma cell disorders with research interests in immunotherapy for myeloma, optimal care of older adults with myeloma, and reducing infectious risks in myeloma patients.

Disclosures

Dr. PIanko reports the following:

Consulting: Janssen, GlaxoSmithKline, Pfizer, Sanofi, Oncopeptides

Research Support: Abbvie, Pfizer, Bristol-Myers Squibb, Regeneron, Sanofi, Nektar

Recent Contributions to PracticeUpdate:

  1. Teclistamab in Relapsed or Refractory Multiple Myeloma

Most Read This Week

Recently Updated